May 13 – 14, 2019: Bergen, Norway
Poster Presentation:
BGB149, a novel clinical stage humanised anti-AXL function blocking antibody
Selective AXL inhibitors
May 13 – 14, 2019: Bergen, Norway
Poster Presentation:
BGB149, a novel clinical stage humanised anti-AXL function blocking antibody
Please remember to confirm your email by clicking on the link provided in the subscription confirmation email. We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.